Showing results (61-70 of 336) with videos related to
Sort By:
Pageof 34
Expert Review of Hematology|January 21, 2020
A comprehensive evaluation of apixaban in the treatment of venous thromboembolismJennifer L Koehl, Bryan D Hayes, Hanny Al-Samkari, et al.Neuro-Oncology|October 14, 2021
Characterization and prognosis of temozolomide-induced aplastic anemia in patients with central nervous system malignanciesAlbert K Park, Anem Waheed, Deborah A Forst, et al.British Journal of Haematology|May 17, 2018
Romiplostim for the management of perioperative thrombocytopeniaHanny Al-Samkari, Ariela L Marshall, Katayoon Goodarzi, et al.Thrombosis Research|May 10, 2023
Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping reviewEllen Zhang, Zain M Virk, Josanna Rodriguez-Lopez, et al.Blood Advances|April 9, 2024
Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in womenEllen Zhang, Zain M Virk, Josanna Rodriguez-Lopez, et al.Cancer|June 29, 2022
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancerNathan W Watson, Seth A Wander, Joseph J Shatzel, et al.Journal of Thrombosis and Thrombolysis|July 13, 2022
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacementZain M Virk, Andrew B Song, Yousef R Badran, et al.American Journal of Hematology|September 23, 2021
Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemiaZain M Virk, Arpan A Patel, Rebecca K Leaf, et al.Cancer Medicine|August 13, 2024
Romiplostim in chemotherapy-induced thrombocytopenia: A review of the literatureGerald A Soff, Hanny Al-Samkari, Avi Leader, et al.Journal of Thrombosis and Thrombolysis|October 25, 2021
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasiaAbraham Z Cheloff, Andrew B Song, Kristin M D'Silva, et al.Pageof 34